Cargando…

The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy

Ischemic cardiomyopathy (ICM) is becoming a leading cause of morbidity and mortality in the whole world. Stem cell-based therapy is emerging as a promising option for treatment of ICM. Several stem cell types including cardiac-derived stem cells (CSCs), bone marrow-derived stem cells, mesenchymal st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xianyun, Zhang, Jun, Zhang, Fan, Li, Jing, Li, Yaqi, Tan, Zirui, Hu, Jie, Qi, Yixin, Li, Quanhai, Yan, Baoyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460238/ https://www.ncbi.nlm.nih.gov/pubmed/26101528 http://dx.doi.org/10.1155/2015/135023

Ejemplares similares

Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells
por: Li, Shujing, et al.
Publicado: (2016)

The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease
por: Zhang, Jun, et al.
Publicado: (2016)

The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction
por: Wang, Xianyun, et al.
Publicado: (2021)

Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
por: Li, Yanjia, et al.
Publicado: (2015)

Clinical mesenchymal stem cell therapy in ischemic cardiomyopathy
por: Mazine, Amine, et al.
Publicado: (2021)

Bioinformatics Analysis and Identification of Genes and Pathways in Ischemic Cardiomyopathy
por: Cao, Jing, et al.
Publicado: (2021)

Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2021)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy
por: Zhang, Zhi-hua, et al.
Publicado: (2020)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Effect of IL-17 in the development of colon cancer in mice
por: Yang, Lijuan, et al.
Publicado: (2016)

Effects of stem cell therapy on dilated cardiomyopathy
por: Jiao, Rong, et al.
Publicado: (2014)

Ferroptosis and Autophagy-Related Genes in the Pathogenesis of Ischemic Cardiomyopathy
por: Zheng, Yue, et al.
Publicado: (2022)

Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy
por: Wang, Qi, et al.
Publicado: (2017)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Reversal of Ischemic Cardiomyopathy with Sca-1(+) Stem Cells Modified with Multiple Growth Factors
por: Li, Ning, et al.
Publicado: (2014)

Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy
por: Hua, Ping, et al.
Publicado: (2015)

Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022)

Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy
por: Liu, Muyin, et al.
Publicado: (2023)

Identification of potential genes for human ischemic cardiomyopathy based on RNA-Seq data
por: Li, Wan, et al.
Publicado: (2016)

Correction: Reversal of Ischemic Cardiomyopathy with Sca-1(+) Stem Cells Modified with Multiple Growth Factors
por: Li, Ning, et al.
Publicado: (2020)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

Cardiac Magnetic Resonance for evaluating early outcomes of stem cell therapy in non-ischemic dilated cardiomyopathy
por: Gulati, Gurpreet S, et al.
Publicado: (2011)

Commentary: Mending a broken heart: The ongoing quest for mesenchymal stem cell therapy for ischemic cardiomyopathy
por: Spinetti, Gaia, et al.
Publicado: (2021)

Protective Effects of Chronic Intermittent Hypobaric Hypoxia Pretreatment against Aplastic Anemia through Improving the Adhesiveness and Stress of Mesenchymal Stem Cells in Rats
por: Yang, Jing, et al.
Publicado: (2017)

Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2022)

Efficacy of Stem Cell Therapy in Large Animal Models of Ischemic Cardiomyopathies: A Systematic Review and Meta-Analysis
por: La Mantia, Debora, et al.
Publicado: (2022)

Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease
por: Zhu, Kai, et al.
Publicado: (2016)

Multimodality Imaging in Ischemic Cardiomyopathy
por: Prior, John O., et al.
Publicado: (2014)

A TRPV1 common missense variant affected the prognosis of ischemic cardiomyopathy
por: Li, Shiyang, et al.
Publicado: (2022)

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
por: Tompkins, Bryon A., et al.
Publicado: (2018)

Decreased eGFR Is Associated With Ischemic Stroke in Patients With Dilated Cardiomyopathy
por: Deng, Yuqing, et al.
Publicado: (2019)

Calculated plasma volume status is associated with poor outcomes in acute ischemic stroke treated with endovascular treatment
por: Zhang, Dixia, et al.
Publicado: (2023)

Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy
por: Huang, Rongchong, et al.
Publicado: (2018)

The Prediction of the Gas Utilization Ratio Based on TS Fuzzy Neural Network and Particle Swarm Optimization
por: Zhang, Sen, et al.
Publicado: (2018)

Stem Cell-Based Therapy for Experimental Ischemic Stroke: A Preclinical Systematic Review
por: Zhang, Xi-Le, et al.
Publicado: (2021)

Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy
por: Chang, Xing, et al.
Publicado: (2023)

Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning
por: Crisafulli, Antonio, et al.
Publicado: (2020)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d53jnmit5bsuehcneii3g3h2hb